YuanMing Capital is a healthcare specialty fund focusing on China-US cross border investments with offices in Beijing and New York City. The investment team has rich industry experience and a successful investment track record. The fund invests in therapeutics, medical devices, diagnostics as well as healthcare service companies based in US and/or China. We seek to bring capital and strategic resources to the future leaders of the industry. Why we are unique: • Exceptional network and capital markets experience in both China and US, • Strong operational and investment capability as well as broad biotech industry experience, • World-class expert network and advisory team, • Localization capabilities in the Chinese market.